Germany, UK trade words over efficacy of AstraZeneca covid vaccine
London, Jan. 29, 2021 (AltAfrica)-The efficacy of AstraZeneca covid vaccine is the subject of a huge controversy between Germany and United Kingdom, UK over the suitability of the vaccine for certain age group
Germany’s vaccine committee said AstraZeneca’s Covid jab is not suitable for people aged 65 and above and that should only be given to people aged under 65.
German government advisors said AstraZeneca’s Covid-19 vaccine shouldn’t be administered to people over 65 years of age https://t.co/qB28kQRlNy— The Wall Street Journal (@WSJ) January 28, 2021
The committee cited “insufficient data” over its efficacy for older people.
But UK The prime minister Boris Johnson and Public Health England have both defended the use of the Oxford-AstraZeneca jab, after Germany recommended that it should only be given to people aged under 65.
Dr Mary Ramsay of PHE said the jab offers “high levels of protection” against Covid-19, particularly against severe illness.
Boris Johnson said he was not concerned by Germany’s recommendation.
AstraZeneca said the jab’s trial data supported efficacy in the over-65s.
The European Medicines Agency is to decide on Friday whether to approve the vaccine for use across the EU.
But Dr Ramsay, head of immunisations at Public Health England, said: “Both the AstraZeneca and Pfizer-BioNTech vaccines are safe and provide high levels of protection against Covid-19, particularly against severe disease.
“There were too few cases in older people in the AstraZeneca trials to observe precise levels of protection in this group, but data on immune responses were very reassuring.”
UK Prime Minister Boris Johnson said he was not worried by the German recommendation, saying British health authorities had made clear the AstraZeneca vaccine was “effective across all age groups”.